Open Beta
MetriLume

US marketsCSTL

SEC-sourced researchBeta

CSTL

CASTLE BIOSCIENCES INC

Company comparison ↗

Data passport

CIK
0001447362
Exchange
Nasdaq
Business activity
— · SIC 8071
Financial inputs
6/6
Filing date
Oct 5, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 219,788,000.0000 USD; December 2024: 332,069,000.0000 USD; December 2025: 344,229,000.0000 USD344.2M USD0 USD0December 2023December 2024December 2025
CSTL · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2023219,788,000.0000Feb 26, 2026
December 2024332,069,000.0000Feb 26, 2026
December 2025344,229,000.0000Feb 26, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025344,229,000.0000-24,158,000.000064,347,000.0000578,556,000.0000107,683,000.0000Feb 26, 2026
December 2024332,069,000.000018,245,000.000064,866,000.0000531,235,000.000075,400,000.0000Feb 26, 2026
December 2023219,788,000.0000-57,466,000.0000-5,626,000.0000——Feb 26, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$344.23MDecember 2025Feb 26, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$332.07MDecember 2024Feb 26, 202610-K
Net incomeNetIncomeLoss-$24.16MDecember 2025Feb 26, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$64.35MDecember 2025Feb 26, 202610-K
Total assetsAssets$578.56MDecember 2025Feb 26, 202610-K
Total liabilitiesLiabilities$107.68MDecember 2025Feb 26, 202610-K

New filings

Explore methodology ↗